3 Results for "

IRE1α oligomerization

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "IRE1α oligomerization" in MCE Product Catalog:

  • Targets Recommended:
1
1 Cited Publications
Cat. No.: HY-136735
CAS No.: 2328097-41-0
Purity:  98.94%
Target:  

IRE1

Research Areas:  

Neurological Disease Cancer

IRE1α kinase-IN-1 is a highly selective IRE1α (ERN1) inhibitor, with an IC50 of 77 nM. IRE1α kinase-IN-1 displays 100-fold selectivity for IRE1α over the IRE1β isoform. IRE1α kinase-IN-1 inhibits ER stress-induced IRE1α oligomerization and autophosphorylation, and also inhibits IRE1α RNase activity (IC50=80 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-U00460
Target:  

IRE1

Research Areas:  

Cancer

3,6-DMAD hydrochloride, an acridine derivative, is a potent IRE1α-XBP1s pathway inhibitor. 3,6-DMAD hydrochloride promotes IL-6 secretion via the IRE1α-XBP1s pathway. 3,6-DMAD hydrochloride inhibits IRE1α oligomerization and endoribonuclease (RNase) activity. 3,6-DMAD hydrochloride can be used for research of cancer .
loading...
    loading...
Cat. No.: HY-U00460B
CAS No.: 2226511-77-7
Target:  

IRE1

Research Areas:  

Cancer

3,6-DMAD dihydrochloride, an acridine derivative, is a potent IRE1α-XBP1s pathway inhibitor. 3,6-DMAD dihydrochloride promotes IL-6 secretion via the IRE1α-XBP1s pathway. 3,6-DMAD dihydrochloride inhibits IRE1α oligomerization and endoribonuclease (RNase) activity. 3,6-DMAD dihydrochloride can be used for research of cancer .
loading...
    loading...